ProQR – Patient Worthy

source: pixabay.com

InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials

Post author:Jessica Lynn
Post published:March 23, 2022
Post category:Retinitis pigmentosa usher syndrome

ProQR Therapeutics is working to develop unique therapeutic solutions for genetic eye diseases. Currently, the company is evaluating its therapeutic candidate ultevursen within the Phase 2/3 Sirius and Celeste clinical trials; you can read…

source: pixabay.com

ProQR And The Use of RNA Therapies for Rare Genetic Disorders

Post author:James Moore
Post published:December 5, 2019
Post category:Cystic Fibrosis Leber Congenital Amaurosis usher syndrome

In a story for Drug Development & Delivery, the CEO of the biotechnology company ProQR, Daniel de Boer, recently sat down for an interview. In this interview, Mr. de Boer…

InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials

ProQR And The Use of RNA Therapies for Rare Genetic Disorders

Let’s Work Together!

Keep Up to Date

Learn More